ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Bristol Myers Squibb at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Bristol Myers Squibb brings 5 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 2106. Its program centres on immune-targeted approaches to lupus and rheumatoid arthritis, including TLR7 and TLR8 blockade, TYK2 inhibition and CD19 CAR T platforms that aim to reset the immune system.

OrganizationACR Convergence 2026 Attendance
Bristol Myers Squibb
Lawrence Township, NJ
Pharmaceutical companies
A biopharmaceutical company that develops and markets medicines.
Booth
Exhibiting at Booth 2106
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Industry
Mon Nov 9
5:30pm–7:30pm
Reframing Lupus Care: Emerging TYK2 Inhibitors and the Future of Treat-to-Target Management in SLE
Hyatt Regency Orlando, Regency Ballroom O
Lupus · with Oklahoma Medical Research Foundation, University of Pennsylvania

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Bristol Myers Squibb

Tell us what you sell and we’ll find the people at Bristol Myers Squibb most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction